CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $561.68 | $45K | 333,743 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $563.31 | $90K | 333,583 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −94 | $567.90 | $53K | 333,489 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −306 | $569.65 | $174K | 333,183 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −534 | $570.55 | $305K | 332,649 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $571.52 | $183K | 332,329 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −560 | $572.86 | $321K | 331,769 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $573.62 | $161K | 331,489 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −830 | $574.94 | $477K | 330,659 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,346 | $575.90 | $775K | 329,313 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −774 | $576.91 | $447K | 328,539 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −930 | $577.93 | $537K | 327,609 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $579.02 | $185K | 327,289 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −864 | $580.20 | $501K | 326,425 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −702 | $581.21 | $408K | 325,723 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −520 | $582.24 | $303K | 325,203 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $583.28 | $233K | 324,803 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −360 | $584.66 | $210K | 324,443 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 318,910 | ||
| 2026-10-01 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise 10b5-1 | +8,300 | $146.03 | $1.2M | 53,472 |
Page 27 of 121 · 2,404 trades